155 related articles for article (PubMed ID: 32905596)
21. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
[TBL] [Abstract][Full Text] [Related]
22. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
23. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
[TBL] [Abstract][Full Text] [Related]
24. Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
van der Waart AB; van der Velden WJ; van Halteren AG; Leenders MJ; Feuth T; Blijlevens NM; van der Voort R; Dolstra H
PLoS One; 2012; 7(12):e50896. PubMed ID: 23226545
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.
Aoyama K; Saha A; Tolar J; Riddle MJ; Veenstra RG; Taylor PA; Blomhoff R; Panoskaltsis-Mortari A; Klebanoff CA; Socié G; Munn DH; Murphy WJ; Serody JS; Fulton LM; Teshima T; Chandraratna RA; Dmitrovsky E; Guo Y; Noelle RJ; Blazar BR
Blood; 2013 Sep; 122(12):2125-34. PubMed ID: 23814022
[TBL] [Abstract][Full Text] [Related]
26. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
27. Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation.
Allie SR; Zhang W; Tsai CY; Noelle RJ; Usherwood EJ
J Immunol; 2013 Mar; 190(5):2178-87. PubMed ID: 23338237
[TBL] [Abstract][Full Text] [Related]
28. Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity.
Haug T; Aigner M; Peuser MM; Strobl CD; Hildner K; Mougiakakos D; Bruns H; Mackensen A; Völkl S
Front Immunol; 2019; 10():883. PubMed ID: 31105702
[TBL] [Abstract][Full Text] [Related]
29. S1PR5 regulates NK cell responses in preventing graft-versus-host disease while preserving graft-versus-tumour activity in a murine allogeneic haematopoietic stem cell transplantation model.
Wang F; Zhao S; Gu Z; Zhao X; Yang N; Guan L; Liu T; Wang L; Fang S; Zhu C; Luo L; Li M; Wang L; Gao C
Hematol Oncol; 2020 Feb; 38(1):89-102. PubMed ID: 31465552
[TBL] [Abstract][Full Text] [Related]
30. A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody.
He S; Cao Q; Qiu Y; Mi J; Zhang JZ; Jin M; Ge H; Emerson SG; Zhang Y; Zhang Y
J Immunol; 2008 Dec; 181(11):7581-92. PubMed ID: 19017947
[TBL] [Abstract][Full Text] [Related]
31. Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells.
Monlish DA; Beezhold KJ; Chiaranunt P; Paz K; Moore NJ; Dobbs AK; Brown RA; Ozolek JA; Blazar BR; Byersdorfer CA
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291733
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
33. Host-reactive CD8+ memory stem cells in graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
Nat Med; 2005 Dec; 11(12):1299-305. PubMed ID: 16288282
[TBL] [Abstract][Full Text] [Related]
34. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
[TBL] [Abstract][Full Text] [Related]
35. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
36. CD4
Alhaj Hussen K; Michonneau D; Biajoux V; Keita S; Dubouchet L; Nelson E; Setterblad N; Le Buanec H; Bouaziz JD; Guimiot F; Socié G; Canque B
Front Immunol; 2020; 11():579776. PubMed ID: 33329550
[TBL] [Abstract][Full Text] [Related]
37. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
38. The immunopathology of upper gastrointestinal acute graft-versus-host disease. Lymphoid cells and endothelial adhesion molecules.
Roy J; Platt JL; Weisdorf DJ
Transplantation; 1993 Mar; 55(3):572-8. PubMed ID: 7681225
[TBL] [Abstract][Full Text] [Related]
39. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
[TBL] [Abstract][Full Text] [Related]
40. Disturbance in the reconstitution of distinct T-cell subsets and the incidence of GvHD following allo-HSCT in pediatric patients with non-malignant hematological disorders.
Bayegi SN; Hamidieh AA; Behfar M; Bozorgmehr M; Saghazadeh A; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Shekarabi M; Rezaei N
Immunol Lett; 2023 Sep; 261():25-36. PubMed ID: 37474024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
